GOG-0249
Terminated
Protocol Information
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma
Principal Investigator
Marcus Randall
Status
Terminated
Closed to Accrual
February 4, 2013
Closed to Accrual & Treatment
February 4, 2013
Closed to Accrual & Treatment
May 21, 2013
Complete
July 17, 2020
Terminated
July 17, 2020
Disease Site
Gynecologic [GY] Uterine Corpus
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if treatment with vaginal cuff brachytherapy followed by three cycles of chemotherapy reduces the rate of recurrence or death (i.e. increases recurrence-free survival) when compared to pelvic radiation therapy.
Patient Population
Patients with high risk, early stage endometrial cancer.
Target Accrual
562
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.